or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    CRH C -1.45 4.39
    NVS D -0.07 4.30
    SONY C -1.91 3.17

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Animal Health Animation Antibiotics Asphalt Biotechnology Blood Test Building Materials Cement Concrete Concrete Products Construction Consumer Electronics Contact Lens Contact Lenses Diagnostic Products Disposable Product Disposable Products Drugs Electric Vehicle Industry
    Industries: Building Materials Consumer Electronics Drug Manufacturers - Major

    Recent News for John Hancock Disciplined Value International Select ETF & its Holdings

    Date Stock Title
    Oct 2 CRH FIDO AI Raises Series B Investment to Scale Its Innovative Water Management Technology
    Oct 2 NVS Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
    Oct 1 NVS US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
    Oct 1 SONY Sony's Power Play: Ravi Ahuja To Lead Sony Pictures Entertainment After CEO Shake-Up
    Oct 1 NVS Teva launches first U.S. generic against Novartis antidiarrheal Sandostatin LAR
    Sep 30 SONY Sony Pictures, Studio Behind ‘The Crown’ and ‘Jeopardy,’ Gets a New Boss
    Sep 30 SONY What We Learned About Death Stranding 2 At Tokyo Game Show 2024
    Sep 30 NVS Top Research Reports for Apple, Tesla & T-Mobile US
    Sep 30 NVS Novartis: Value Continues To Build With Double-Digit Percentage Growth Products
    Sep 30 NVS Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
    Sep 29 SONY Consumer Tech News (Sept 23- Sept 27): OpenAI pitched President Biden For Expansion Of Data Centers, Apple Discontinued iPhone 15 And 13 Models & More
    Sep 29 CRH CRH plc (NYSE:CRH) is a favorite amongst institutional investors who own 84%
    Sep 28 CRH Is CRH (CRH) the Most Undervalued European Stock To Invest In Now?
    Sep 27 NVS Volkswagen, Novartis could surprise in Q3 earnings season, UBS analysts warn
    Sep 26 SONY Ubisoft Faces Challenges: Star Wars Outlaws' Sales Struggles, Assassin's Creed Shadows Delay, Employee Strikes Ahead
    Sep 26 NVS Novartis: Best Performing Big Pharma Of Past 6 Months Still Looks A Solid Long-Term Bet
    Under normal market conditions, the fund invests at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of equity and equity-related securities issued by non-U.S. large and mid-capitalization companies that meet the fund"s value criteria. The fund generally invests in the equity securities of issuers the manager believes are undervalued. The fund is non-diversified.
    Investment Management Stock Fund Financial Market Private Equity Real Estate
    Back to the Main JDVI Page...